Integrative molecular profiling identifies a novel cluster of estrogen receptor-positive breast cancer in very young women.

Cancer Sci · 2019 · PMC6500962 · PMID 30811755

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Group B patients (5‐year survival rate, .78; average DFS, 30.6) showed a trend toward poorer prognosis than group A (5‐year survival rate, .91; average DFS, 41.5 months) and a shorter disease‐free survival compared with patients in group C (5‐year survival rate, .79; average DFS, 35.0 months; Figure 3 D).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.